PharmaCyte Biotech PMCB
NASDAQ PMCB
$0.53 +0.02 (+3.64%)
At close: Aug 21, 2026 · 4:00 PM EDT

PharmaCyte Biotech (PMCB) Property, Plant & Equipment (Net) (2011 - 2012)

PharmaCyte Biotech (PMCB) Property, Plant & Equipment (Net) (2011 - 2012) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 2.06 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.64 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 554.14 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 6.80 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 107.22 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 PharmaCyte Biotech 4.38 Mn 4.38 Mn - -

Historic Data

Download Data
DateValue
Jan 31, 2012 30,587.00
Jan 31, 2012 30,587.00
Oct 31, 2011 38,060.00
Oct 31, 2011 38,060.00
Jul 31, 2011 45,917.00
Jul 31, 2011 45,917.00
Apr 30, 2011 54,440.00
Apr 30, 2011 54,440.00